
USD
+$0.00
(+0.00%
)At Close (As of Nov 26, 2025)
$14.83M
Market Cap
-
P/E Ratio
-0.05
EPS
$32.00
52 Week High
$0.47
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $381K |
| Total Revenue | $448K |
| Cost Of Revenue | $67K |
| Costof Goods And Services Sold | $67K |
| Operating Income | -$770K |
| Selling General And Administrative | $751K |
| Research And Development | $93K |
| Operating Expenses | $1.2M |
| Investment Income Net | - |
| Net Interest Income | - |
| Interest Income | - |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $72K |
| Income Before Tax | -$639K |
| Income Tax Expense | $22K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$661K |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$662K |
| Ebitda | -$590K |
| Net Income | -$661K |
| Field | Value (USD) |
|---|---|
| Total Assets | $6.7M |
| Total Current Assets | $6.7M |
| Cash And Cash Equivalents At Carrying Value | $6.2M |
| Cash And Short Term Investments | $6.2M |
| Inventory | $117K |
| Current Net Receivables | $308K |
| Total Non Current Assets | $46K |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | - |
| Intangible Assets Excluding Goodwill | - |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $92K |
| Other Non Current Assets | - |
| Total Liabilities | $539K |
| Total Current Liabilities | $539K |
| Current Accounts Payable | $10K |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $248K |
| Total Non Current Liabilities | $0 |
| Capital Lease Obligations | $0 |
| Long Term Debt | - |
| Current Long Term Debt | $248K |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $248K |
| Other Current Liabilities | $102K |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $6.2M |
| Treasury Stock | - |
| Retained Earnings | -$523K |
| Common Stock | $1.4K |
| Common Stock Shares Outstanding | $13M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$775K |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $72K |
| Capital Expenditures | $861 |
| Change In Receivables | - |
| Change In Inventory | -$68K |
| Profit Loss | - |
| Cashflow From Investment | -$861 |
| Cashflow From Financing | $6.7M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $0 |
| Dividend Payout Common Stock | $0 |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$661K |
| Field | Value (USD) |
|---|---|
| Gross Profit | $381K |
| Total Revenue | $448K |
| Cost Of Revenue | $67K |
| Costof Goods And Services Sold | $67K |
| Operating Income | -$770K |
| Selling General And Administrative | $751K |
| Research And Development | $93K |
| Operating Expenses | $1.2M |
| Investment Income Net | - |
| Net Interest Income | - |
| Interest Income | - |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $72K |
| Income Before Tax | -$639K |
| Income Tax Expense | $22K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$661K |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$662K |
| Ebitda | -$590K |
| Net Income | -$661K |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Pheton Holdings Ltd Class A Ordinary Shares is a leading healthcare technology company focused on revolutionizing cancer treatment through its cutting-edge software and devices designed for brachytherapy, a specialized form of radiation therapy. With a robust commitment to research and development, Pheton is dedicated to improving patient outcomes by delivering targeted and efficient therapeutic solutions. As the healthcare sector continues to evolve, Pheton is well-positioned to capitalize on the growing demand for innovative cancer treatment technologies, reinforcing its status as a key player in the oncology landscape.